Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV001018239 | SCV001179449 | uncertain significance | Hereditary cancer-predisposing syndrome | 2019-06-04 | criteria provided, single submitter | clinical testing | The p.Q291P variant (also known as c.872A>C), located in coding exon 7 of the NBN gene, results from an A to C substitution at nucleotide position 872. The glutamine at codon 291 is replaced by proline, an amino acid with similar properties. This amino acid position is poorly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Baylor Genetics | RCV004569969 | SCV005056153 | uncertain significance | Aplastic anemia | 2024-02-08 | criteria provided, single submitter | clinical testing |